TATVA Q1 FY27 results at a glance
TATVA CHIN PHARM CHEM LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹167 cr |
|---|
| Revenue YoY | +42.9% |
|---|
| Operating profit | ₹21.73 cr |
|---|
| Operating margin | 13.0% |
|---|
| Net profit | ₹15.98 cr |
|---|
| Net profit YoY | +140.3% |
|---|
| Net profit QoQ | +54.8% |
|---|
| Net margin | 9.6% |
|---|
| Basic EPS | ₹6.83 |
|---|
| TTM revenue | ₹556 cr |
|---|
| TTM net profit | ₹51.38 cr |
|---|
| TTM net margin | 9.2% |
|---|
TATVA Q1 FY27 results: what the numbers say
TATVA CHIN PHARM CHEM LTD (TATVA) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹167 cr and a net profit of ₹15.98 cr, translating into earnings per share of ₹6.83.
Compared with the same quarter a year earlier, revenue grew strongly by +42.9% and net profit grew sharply by +140.3%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹21.73 cr, an operating margin of 13.0% versus 7.2% a year ago — a gain of 5.9 percentage points.
TATVA quarter-wise results table
Net profit
₹15.98 cr
+140.3% YoY
Operating profit
₹21.73 cr
+160.0% YoY
TATVA CHIN PHARM CHEM LTD (TATVA) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹167 cr | ₹21.73 cr | ₹15.98 cr | 13.0% | 9.6% | ₹6.83 | +140.3% | +54.8% |
| Q4 FY262026-03-31 | ₹134 cr | ₹18.37 cr | ₹10.32 cr | 13.7% | 7.7% | ₹4.41 | — | -31.9% |
| Q3 FY262025-12-31 | ₹131 cr | ₹16.42 cr | ₹15.17 cr | 12.5% | 11.5% | ₹6.49 | — | +52.9% |
| Q2 FY262025-09-30 | ₹124 cr | ₹13.16 cr | ₹9.92 cr | 10.7% | 8.0% | ₹4.24 | — | +49.1% |
| Q1 FY262025-06-30 | ₹117 cr | ₹8.36 cr | ₹6.65 cr | 7.2% | 5.7% | ₹2.84 | — | — |
| TTM (last 4 quarters) | ₹556 cr | ₹69.68 cr | ₹51.38 cr | 12.5% | 9.2% | ₹21.97 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
TATVA quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
TATVA CHIN PHARM CHEM LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹167 cr | ₹134 cr | ₹131 cr | ₹124 cr | ₹117 cr |
|---|
| Total expenses | ₹145 cr | ₹116 cr | ₹115 cr | ₹110 cr | ₹109 cr |
|---|
| Gross profit | ₹91.76 cr | ₹77.96 cr | ₹76.19 cr | ₹68.65 cr | ₹58.52 cr |
|---|
| Operating profit (EBIT) | ₹21.73 cr | ₹18.37 cr | ₹16.42 cr | ₹13.16 cr | ₹8.36 cr |
|---|
| Operating margin | 13.0% | 13.7% | 12.5% | 10.7% | 7.2% |
|---|
| Interest cost | ₹2.08 cr | ₹1.44 cr | ₹0.49 cr | ₹0.51 cr | ₹0.41 cr |
|---|
| Profit before tax | ₹21.11 cr | ₹16.59 cr | ₹17.66 cr | ₹13.66 cr | ₹9.1 cr |
|---|
| Tax expense | ₹5.13 cr | ₹6.27 cr | ₹2.49 cr | ₹3.75 cr | ₹2.45 cr |
|---|
| Effective tax rate | 24.3% | 37.8% | 14.1% | 27.4% | 26.9% |
|---|
| Net profit (PAT) | ₹15.98 cr | ₹10.32 cr | ₹15.17 cr | ₹9.92 cr | ₹6.65 cr |
|---|
| Net profit margin | 9.6% | 7.7% | 11.5% | 8.0% | 5.7% |
|---|
| Basic EPS | ₹6.83 | ₹4.41 | ₹6.49 | ₹4.24 | ₹2.84 |
|---|
| Diluted EPS | ₹6.83 | ₹4.41 | ₹6.49 | ₹4.24 | ₹2.84 |
|---|
TATVA results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +42.9% | — | — | — | — |
|---|
| Revenue QoQ | +24.5% | +2.1% | +6.3% | +5.7% | — |
|---|
| Operating profit YoY | +160.0% | — | — | — | — |
|---|
| Operating profit QoQ | +18.3% | +11.9% | +24.7% | +57.5% | — |
|---|
| Net profit YoY | +140.3% | — | — | — | — |
|---|
| Net profit QoQ | +54.8% | -31.9% | +52.9% | +49.1% | — |
|---|
| EPS YoY | +140.5% | — | — | — | — |
|---|
| EPS QoQ | +54.9% | -32.0% | +53.1% | +49.3% | — |
|---|
TATVA annual results history
Full-year performance for TATVA CHIN PHARM CHEM LTD, useful for reading each quarter in context.
TATVA CHIN PHARM CHEM LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹501 cr | ₹380 cr | ₹390 cr | ₹421 cr |
|---|
| Total expenses | ₹441 cr | ₹373 cr | ₹346 cr | ₹362 cr |
|---|
| Gross profit | ₹263 cr | ₹172 cr | ₹208 cr | ₹186 cr |
|---|
| Operating profit (EBIT) | ₹59.4 cr | ₹6.91 cr | ₹44.12 cr | ₹58.74 cr |
|---|
| Operating margin | 11.9% | 1.8% | 11.3% | 14.0% |
|---|
| Interest cost | ₹2.62 cr | ₹0.9 cr | ₹6.15 cr | ₹8 cr |
|---|
| Profit before tax | ₹57.01 cr | ₹7.58 cr | ₹43.57 cr | ₹44.78 cr |
|---|
| Tax expense | ₹14.96 cr | ₹1.87 cr | ₹13.21 cr | -₹0.71 cr |
|---|
| Effective tax rate | 26.2% | 24.6% | 30.3% | -1.6% |
|---|
| Net profit (PAT) | ₹42.05 cr | ₹5.71 cr | ₹30.35 cr | ₹45.49 cr |
|---|
| Net profit margin | 8.4% | 1.5% | 7.8% | 10.8% |
|---|
| Basic EPS | ₹17.98 | ₹2.44 | ₹13.26 | ₹20.52 |
|---|
| Diluted EPS | ₹17.98 | ₹2.44 | ₹13.26 | ₹20.52 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹167 cr against ₹117 cr in Q1 FY26, and ₹134 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +24.5%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹145 cr, or 87.0% of revenue, with operating profit grew +160.0% year on year.
Margins, tax and profitability
Net profit of ₹15.98 cr works out to a net margin of 9.6% compared with 5.7% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, TATVA CHIN PHARM CHEM LTD reported profit before tax of ₹21.11 cr, a tax charge of ₹5.13 cr (effective rate 24.3%), interest cost of ₹2.08 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹10.32 cr in Q4 FY26 to ₹15.98 cr in Q1 FY27, a change of +54.8%.
Trailing twelve months and annual context
Across the trailing four quarters TATVA CHIN PHARM CHEM LTD has generated revenue of ₹556 cr and net profit of ₹51.38 cr, a trailing net margin of 9.2%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹501 cr with net profit of ₹42.05 cr and EPS of ₹17.98, versus the prior year where revenue grew +31.8% and profit grew +636.1%.
What to watch in the next TATVA quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
TATVA CHIN PHARM CHEM LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
TATVA results coverage
No results report published for TATVA yet — our desk covers each quarter within minutes of the filing.
TATVA quarterly results FAQs
What were TATVA CHIN PHARM CHEM LTD (TATVA) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), TATVA CHIN PHARM CHEM LTD reported revenue of ₹167 cr and net profit of ₹15.98 cr, a change of +140.3% year on year on +42.9% revenue growth. EPS stood at ₹6.83.
What is TATVA profit margin in Q1 FY27?
TATVA CHIN PHARM CHEM LTD posted a net profit margin of 9.6% and an operating margin of 13.0% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹556 cr and net profit ₹51.38 cr.
Did TATVA results beat the previous quarter?
TATVA CHIN PHARM CHEM LTD net profit changed +54.8% quarter on quarter, from ₹10.32 cr in Q4 FY26 to ₹15.98 cr in Q1 FY27.
When are TATVA CHIN PHARM CHEM LTD (TATVA) quarterly results?
TATVA CHIN PHARM CHEM LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see TATVA latest quarterly results?
Results coverage for TATVA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the TATVA stock page.
What is TATVA CHIN PHARM CHEM LTD annual revenue and profit?
For FY26, TATVA CHIN PHARM CHEM LTD reported full-year revenue of ₹501 cr and net profit of ₹42.05 cr, with EPS of ₹17.98.
How many quarterly results has TATVA declared recently?
Past results dates for TATVA will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
